Intensive care unit-acquired weakness: From molecular mechanisms to its impact in COVID-2019
Intensive Care Unit-Acquired Weakness (ICU-AW) is a generalized and symmetric neuromuscular dysfunction associated with critical illness and its treatments. Its incidence is approximately 80% in intensive care unit patients, and it manifests as critical illness polyneuropathy, critical illness myopa...
Saved in:
Main Authors: | Andrea Gonzalez (Author), Johanna Abrigo (Author), Oscar Achiardi (Author), Felipe Simon (Author), Claudio Cabello-Verrugio (Author) |
---|---|
Format: | Book |
Published: |
PAGEPress Publications,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of exercise training on the sarcopenia criteria in non-alcoholic fatty liver disease: a systematic review and meta-analysis
by: Andrea Gonzalez, et al.
Published: (2021) -
Angiotensin-(1-7) improves skeletal muscle regeneration
by: Mayalen Valero-Breton, et al.
Published: (2023) -
Prolonged glucocorticoid treatment in ARDS: impact on intensive care unit acquired weakness.
by: Gianfranco Umberto Meduri, et al.
Published: (2016) -
Effect of physiotherapy on regaining independent walking in patients with intensive-care-unit-acquired muscle weakness: A cohort study
by: Simone Thomas, et al.
Published: (2019) -
En systematisk litteraturstudie om betydningen av ulike ernæringsintervensjoner på utvikling av intensive care unit acquired weakness
by: Åse Østbø Sørmoen, et al.
Published: (2022)